AntiCA Biomed

is a newly formed (Sept 2020), international biomedical company (San Diego, California, USA) specializing in radical cancer treatment and developing systemic anti-aging therapy. The company conducts preclinical and clinical trials leading to the implementation of innovative therapies designed to prevent, treat various types of cancer, and eliminating aging. The company has already received seed financing commitments.

The Company technology is based on 30 years of research for a novel type of Reprogramming Formula (RF*) for the treatment of cancer patients practically for all types of malignant tumors. The proposed cancer treatment approach also has enormous potential for the development of technology resulting in radical systemic rejuvenation. The main ideas of the novel approach concept has already been published in peer-reviewed scientific journals, presented at major conferences and tested in preclinical studies.